Delivery Order SPE2DB22D1017-SPE2DB24FG2XK
Award Date
8/9/24
Potential Completion Date
8/12/24
Potential Value
$9.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Pulmozyme 1 mg/ml ampul 2.5 ml. The contract has a ceiling value of $3,936.44 and is a firm fixed price contract type. The ultimate completion date is June 26, 2025. The contract is not set aside and was competitively awarded. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of PULMOZYME 1 MG/ML AMPUL 2.5ML. The contract has a ceiling value of $8,513.40 and a period of performance through May 8, 2025. It is a firm-fixed-price contract, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $6,906.45 contract is for the supply of Pulmozyme, a 1 mg/ml ampul with a 2.5 ml volume. The contract has a firm fixed price and is set to expire on June 14, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $8,468.02 firm fixed-price contract is for the supply of Pulmozyme 1 mg/mL ampules (2.5 mL). The award is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Pulmozyme 1 mg/ml ampul 2.5 ml, a pharmaceutical product. The contract has a firm fixed price, a ceiling value of $7,300.97, and a period of performance through June 24, 2025. This award is not designated as a set-aside contract. AmerisourceBergen Drug Corp is the prime...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,472.72, is for the delivery of PULMOZYME 1 MG/ML AMPUL 2.5ML, a specialty pharmaceutical product. The contract has a completion date of January 21, 2025 and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of Pulmozyme 1 mg/ml ampul 2.5 ml, a medication used to treat respiratory conditions. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $3,543.92 and a period of performance ending on June 24, 2025. It is not designated as a set-aside contract. Amerisourcebergen Drug...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Pulmozyme 1 mg/ml ampul 2.5 ml. The contract has a firm fixed price of $4,717.94 and a completion date of December 4, 2024. It is designated as a delivery order contract type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a delivery order awarded to Amerisourcebergen Drug Corporation by the Defense Logistics Agency (DLA) for the supply of Pulmozyme 1 mg/mL ampules. The contract is valued at $10,129.21 and has a firm fixed price pricing type. The place of performance is Conshohocken, Pennsylvania, and the ultimate completion date is September 25, 2024. This contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical,...
The U.S. Defense Logistics Agency (DLA) awarded a $34,729.29 firm-fixed-price delivery order (SPE2DB22D2206|SPE2DB24FDZ63) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Pulmozyme 1 mg/ml ampul 2.5 ml. The order has a completion date of November 3, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive range of...